Posted by Michael Wonder on 15 Jun 2022
PHARMAC announces first round of medicine funding decisions following $191 million pharmaceutical budget increase
15 June 2022 - PHARMAC today announces the first round of changes to medicines funding following its $191 million pharmaceutical budget increase over the next two years.
The first changes include funding blood and breast cancer medicines, widening funded access to eight multiple sclerosis treatments, and changing funding criteria for HIV pre-exposure prophylaxis and post-exposure prophylaxis, making them easier to access.
